Towa Pharmaceutical Co., Ltd.

Overview

Towa Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that focuses mainly on the development and distribution of generic drugs. With its commitment to enhancing healthcare, Towa provides affordable and high-quality medications to support patient care across various therapeutic areas.

Therapeutic areas

API / Drug Master Files

Towa Pharmaceutical Co., Ltd. holds 7 active (31 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LINCOMYCIN HYDROCHLORIDEActive2022-07-28
• INSULIN GLARGINEActive2022-02-16
• CALCIUM GLUCONATE MONOHYDRATE USPActive2017-05-23
• SIMVASTATIN AMMONIUM SALT(DRUG SUBSTANCE INTERMEDIATE)Active2014-01-24
• MAGNESIUM SULFATE HEPTAHYDRATEActive2012-08-08
• MAGNESIUM OXIDE USP LIGHT POWDERActive2009-10-20
• SIMVASTATIN, NON-STERILE BULK FORMActive2006-04-20
• MAGNESIUM OXIDE LIGHT POWDER MP3Inactive2020-12-14
• MAGNESIUM OXIDE LIGHT POWDER MP2Inactive2019-04-17
• MAGNESIUM SULFATE ANHYDROUS, USPInactive2018-10-29
• SODIUM SULFATE ANHYDROUS, USPInactive2018-10-29
• MAGALDRATE POWDER USPInactive2015-12-23
• MAGNESIUM HYDROXIDE NK USPInactive2015-09-22
• USP MAGNESIUM HYDROXIDEInactive2014-12-10
• USP SODIUM SULFATE, ANHYDROUSInactive2012-09-21

Showing 15 of 31 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Towa Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.